Pericytes, inflammation, and diabetic retinopathy
Date
2020
Authors
Spencer, B.G.
Estevez, J.J.
Liu, E.
Craig, J.E.
Finnie, J.W.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Inflammopharmacology, 2020; 28(3):697-709
Statement of Responsibility
Benjamin G. Spencer, Jose J. Estevez, Ebony Liu, Jamie E. Craig, John W. Finnie
Conference Name
Abstract
Diabetic retinopathy (DR) is a frequent complication of diabetes mellitus, and a common cause of vision impairment and blindness in these patients, yet many aspects of its pathogenesis remain unresolved. Furthermore, current treatments are not effective in all patients, are only indicated in advanced disease, and are associated with significant adverse effects. This review describes the microvascular features of DR, and how pericyte depletion and low-grade chronic inflammation contribute to the pathogenesis of this common ophthalmic disorder. Existing, novel and investigational pharmacological strategies aimed at modulating the inflammatory component of DR and ameliorating pericyte loss to potentially improve clinical outcomes for patients with diabetic retinopathy, are discussed.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© Springer Nature Switzerland AG 2019